Experts Question Ethics of Placebo Drug Trials in Case of Ebola

A group of influential health experts has argued the standard practice of using placebos in drug trials would be unethical in the case of experimental medicines for Ebola, given that the world is in the middle of a deadly epidemic. Faced with a disease with a death rate of between 40 and 90 percent, randomized controlled trials (RCTs) -- where patients are assigned to get either the drug or a dummy pill -- would be unfair and ethically unacceptable, according to the disease specialists...

© La Voix de l'Amérique - lundi 13 octobre 2014